47 Best Radiotherapy for Prostate Cancer Doctors Abroad

Prof. Atalar specializes in MR-Guided Adaptive SRS – an advanced precision radiotherapy technique for prostate cancer, developed during her fellowship at Stanford University.

• 20+ years of radiation oncology experience
• Current President of the Turkish Society for Radiation Oncology
• Honorary Fellow of the American College of Radiology
• Former Chair of Young Turkish Society for Radiation Oncology
• Authored 72 peer-reviewed publications

Professor Raimon Miralbell is a world-renowned expert in prostate cancer radiotherapy, collaborating with CERN for advanced treatment research.

• Head of Radiation Oncology at Centro Médico Teknon since 1999
• Specializes in focused radiosurgery techniques like Gammaknife and Cyberknife
• Trained at prestigious institutions including Harvard and Royal Marsden Hospital
• Recipient of the Varian Award for Radiation Oncology
• Published over 100 scientific papers on advanced radiotherapy

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex radiotherapy cases.

• Over 41 years of experience in oncology with a focus on prostate cancer
• Fellowship-trained in sarcoma and brachytherapy at Institut Gustave Roussy
• Associate Professor at Sackler Faculty of Medicine, Tel-Aviv University
• Active member of ESMO and ASCO with numerous research contributions

Dr. Sarid specializes in radiotherapy for prostate cancer at Sourasky Medical Center, with over 38 years of focused oncology experience.

• Trained in cancer urology at Oxford University
• Principal investigator of clinical trials in cancer therapies
• Published 30+ articles on cancer treatment
• Member of The European Society for Medical Oncology

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor Doctor Sefik Igdem specializes in prostate cancer radiotherapy using advanced Truebeam Stx and Halcyons technology at Gayrettepe Florence Nightingale Hospital.

• Over 30 years of experience in radiation oncology
• Expert in conformal treatments for precise targeting
• Former professor at Demiroğlu Bilim University
• Specializes in head and neck cancers alongside prostate cancer

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Solak specializes in radiotherapy for prostate cancer, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at one of Turkey's top cancer institutes
• Trained at MD Anderson – a global leader in cancer treatment
• Experienced with various cancers including prostate cases
• Works at Hisar Hospital Intercontinental's oncology department

Dr. Zuleyha Akgun is a radiation oncology specialist at Memorial Şişli Hospital in Istanbul. She focalizes on cancer treatment using targeted radiation therapy. Dr. Akgun has practiced at some of Turkey’s most active medical institutions since 2003. She serves patients at a JCI-accredited facility recognized for its high medical safety standards.

• Practices at Memorial Şişli Hospital, the first Turkish hospital to earn JCI accreditation.
• Completed a research residency at Marmara University Faculty of Medicine.
• Treats patients in a specialized oncology center that attracts international cases from 160+ countries.
• Previously served as a specialist at Erzurum Regional Training and Research Hospital.

Dr. Mehmet Dogu Canoglu specializes in advanced radiotherapy techniques at Anadolu Medical Center, a leading facility for prostate cancer treatment.

• Completed radiation oncology training at Kocaeli University
• Expert in MR Linac, CyberKnife, and Varian TrueBeam/Trilogy systems
• Joined Anadolu Medical Center in 2017 after hospital experience across Turkey
• Focuses exclusively on radiation oncology

Dr. Alemdar specializes in medical oncology with a focus on prostate cancer at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Extensive experience in internal medicine and oncology
• Practices at a leading hospital complex in Antalya

Phd Viola Fox leads a certified interdisciplinary cancer center, specializing in advanced radiotherapy for prostate cancer.

• Specialized in haematology, oncology, and immunology since 2011
• Chief Physician at BKZ Solingen's cancer center
• Active in molecular biology research for innovative cancer treatments
• Member of German and American oncology societies

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.